Tuesday, March 03, 2015

Dr. Bill Quick's Posts

Diabetes Nurses in the Hospital Setting

I recently read a discussion about "Advocating for better diabetes care in hospitals" and again was reminded of the perpetual problem of providing excellence of diabetes care for hospitalized... Read moreChevron

The Latest “Me-Too” Insulin Product

The manufacturer of a very popular insulin product, Lantus (insulin glargine), has a problem.The drug, which had 5.72 billion euros ($7.7 billion) in sales last year, loses patent protection soon. Typically, when a drug goes off-patent, profits plummet, as competitors flood the market with less-expensive competitors. There's already a ... Read moreChevron

Glucose-Responsive Insulin Could Be The Future Of Insulin

This past week, a press release announced positive results from a mouse-research study of a new insulin—one that adapts to the ambient blood glucose level (BGL) to keep the BGL stable. The press release calls this new insulin... Read moreChevron

Does Diabetes Increase Risk For Viral Hepatitis?

I recently received the following e-mail:

 

"At my last appointment, my endocrinologist said she wanted me to get flu, pneumonia and hep C vaccinations... Is there any reason to believe that people with type 1 diabetes would need the hep C vaccine?"

 

This question raises the issue as to whether... Read moreChevron

Splitting Insulin Glargine Doses

I've been asked (again) about optimizing how to give the dose of Lantus (insulin glargine), so I decided I'll share my thoughts on-line. First, a disclaimer: (1) I previously worked for Aventis and later Sanofi-Aventis, the manufacturer of Read moreChevron